Pharmafile Logo
Pharmafocus logo
Advanced Search

jazz pharmaceuticals

Showing 8 posts of 8 posts found.

jazz_pharma

Jazz acquires GW Pharmaceuticals in $7.2 billion deal

February 4, 2021
cannabinoid, jazz pharmaceuticals

Jazz Pharmaceuticals has acquired GW Pharmaceuticals for over $7 billion, with the transition expected to close in the second quarter …

News
jazz_pharma

Jazz Pharma’s Sunosi becomes first EU-approved drug of its kind in narcolepsy and sleep apnoea

January 21, 2020
Manufacturing and Production, Sales and Marketing jazz pharmaceuticals, narcolepsy, pharma

Jazz Pharmaceuticals has secured approval from the European Commission for Sunosi (solriamfetol), it has emerged, as a therapy to improve …

News
jazz_pharma

FDA authorises Jazz Pharma’s sleep disorder therapy Sunosi

March 22, 2019
Medical Communications, Sales and Marketing FDA, jazz pharmaceuticals, pharma, sleep apnoea

Jazz Pharmaceuticals has announced that its dopamine and norepinephrine reuptake inhibitor (DNRI) Sunosi (solriamfetol) has been approved by the FDA …

News
jazz_pharma

Jazz Pharma’s Vyxeos secures NICE recommendation in acute myeloid leukaemia

November 8, 2018
Sales and Marketing Cancer, NHS, NICE, UK, Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, pharma

Jazz Pharmaceuticals has revealed that NICE has chosen to recommend that its 44mg/100mg powder formulation of Vyxeos for concentrate for …

News
jazz_pharma

Jazz Pharma’s acute myeloid leukaemia drug scores EU approval

August 29, 2018
Research and Development, Sales and Marketing Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, leukaemia, pharma

Jazz Pharmaceuticals has revealed that its advanced liposomal formulation Vyxeos has received approval from the European Commission for the treatment …

News
jazz_pharma

Jazz Pharmaceuticals to expand Irish workforce across Dublin, Athlone sites

August 6, 2018
Manufacturing and Production, Sales and Marketing Dublin, Ireland, jazz pharmaceuticals, pharma

Jazz Pharmaceuticals has announced its intention to expand its staff numbers at two of its bases in its home country …

News
pharma_pill_manufacturing

Jazz Pharmaceuticals UK supplier hit with FDA warning

January 26, 2017
Manufacturing and Production Erwinaze, Porton Biopharma, jazz pharmaceuticals

UK-based Porton Biopharma, supplier of Irish company Jazz Pharmaceuticals’ leukaemia treatment Erwinaze, has been slapped with an FDA warning letter …

News
laboratory-testing-az

Jazz Pharmaceuticals receives FDA approval for rare veno-occlusive disease treatment

March 31, 2016
Research and Development, Sales and Marketing FDA, jazz pharmaceuticals

Jazz Pharmaceuticals (NASDAQ: JAZZ) has announced that the US Food and Drug Administration (FDA) has granted marketing approval for Defitelio …

News

Latest content

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023

EC approves Pfizer’s Litfulo for adolescents and adults with alopecia

September 19, 2023